Tesofensine and beta blocker combination formulations
The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of...
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
25.06.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of treatment of diabetes, obesity, or an obesity associated disorder. |
|---|---|
| AbstractList | The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or carvedilol, or a pharmaceutically acceptable salt thereof. The invention further relates to use of the controlled release formulation in a method of treatment of diabetes, obesity, or an obesity associated disorder. |
| Author | Thomsen, Mikael S Nielsen, Peter G Højgaard, Bent |
| Author_xml | – fullname: Højgaard, Bent – fullname: Thomsen, Mikael S – fullname: Nielsen, Peter G |
| BookMark | eNrjYmDJy89L5WQwDUktzk9LzSvOzEtVSMxLUUhKLUlUSMrJT85OLVJIzs9NysxLLMnMz1NIyy_KLc0Bs4t5GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakl8aLChkYGhmYWJgZORMTFqAJlbL4Q |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | US12016840B2 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_US12016840B23 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 10:38:44 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_US12016840B23 |
| Notes | Application Number: US202217821905 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240625&DB=EPODOC&CC=US&NR=12016840B2 |
| ParticipantIDs | epo_espacenet_US12016840B2 |
| PublicationCentury | 2000 |
| PublicationDate | 20240625 |
| PublicationDateYYYYMMDD | 2024-06-25 |
| PublicationDate_xml | – month: 06 year: 2024 text: 20240625 day: 25 |
| PublicationDecade | 2020 |
| PublicationYear | 2024 |
| RelatedCompanies | SANIONA A/S |
| RelatedCompanies_xml | – name: SANIONA A/S |
| Score | 3.5536501 |
| Snippet | The present invention relates to a controlled release formulation comprising the active compounds tesofensine and a beta blocker, such as metoprolol or... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | Tesofensine and beta blocker combination formulations |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240625&DB=EPODOC&locale=&CC=US&NR=12016840B2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp6LzgwrSt-Jamy59KEK_GMI-cK3sbTQxgSm0Y63473sJnfNF30ICyeXgl99dcncBuBeFZzNJucWkZJZL-JsqeSvQkKN8UAhKCkclOI8n3ih3nxdk0YH3bS6MrhP6pYsjIqI44r3R5_V6d4kV69jK-oGtsKt6SrMgNlvvWNGTQ8w4DJLZNJ5GZhQF-dycvAQ2Ep2qaxLicb2HZjRV4X_Ja6iyUta_KSU9hv0ZzlY2J9ARZQ8Oo-3Paz04GLcP3thssVefAslEXUkVb14KA_1_g6GEBkMy-hAbA6VHH1dLbig7tP2Vqz6DuzTJopGF6y9_NrvM5ztRH8-hW1aluADDEwgW16fFgDKXE9-XCDYm5JBLZ-jZxSX0_56n_9_gFRwpxanwJ4dcQ7fZfIobJNqG3WoNfQNxeoOA |
| link.rule.ids | 230,309,786,891,25585,76894 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7GFOebTkXnrwrSt-Jam659KEJ_UXXthmtlb6PpElChHWvFf99L6Zwv-hYSSK6BL99devcF4JZlhkq5mSuUc6roJF8KyVuGjpyZDzNmkkwTBc5RbISp_jQn8w68b2phGp3Qr0YcERGVI97r5rxebS-xvCa3srqjb9hVPgSJ7cltdCzoSSOy59j-dOJNXNl17XQmxy-2ikQndE0cPK530MW2hM6-_-qIqpTVb0oJDmB3irMV9SF0WNGHnrt5ea0Pe1H7wxubLfaqIyAJq0ou8s0LJmH8L1G0UKJIRh9sLaH1GOM2lkvCD21f5aqO4SbwEzdUcP3Fz8cu0tnW1PsT6BZlwU5BMhiCRbfMbGhSPSeWxRFslPFRzrWRoWZnMPh7nsF_g9fQC5NovBg_xs_nsC82UaRCaeQCuvX6k10i6db0qtmtb8dZhnM |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Tesofensine+and+beta+blocker+combination+formulations&rft.inventor=H%C3%B8jgaard%2C+Bent&rft.inventor=Thomsen%2C+Mikael+S&rft.inventor=Nielsen%2C+Peter+G&rft.date=2024-06-25&rft.externalDBID=B2&rft.externalDocID=US12016840B2 |